Weltelmi 20mg Tablet contains Telmisartan, an angiotensin II receptor blocker (ARB) indicated primarily for the management of hypertension. By selectively inhibiting the binding of angiotensin II to the AT1 receptor subtype found in vascular smooth muscle and the adrenal gland, Telmisartan promotes vasodilation, thereby reducing peripheral vascular resistance and lowering blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Weltelmi 20mg is typically prescribed for adult patients requiring blood pressure control either as monotherapy or in combination with other antihypertensive agents. The tablet is administered orally, with dosage adjusted based on clinical response and patient tolerance. Common adverse effects may include dizziness, headache, and fatigue, although it is generally well tolerated. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated during pregnancy due to potential fetal toxicity. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Weltelmi 20mg provides an effective and convenient option for long-term hypertension management, contributing to the reduction of cardiovascular morbidity and mortality.